[Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population].
A Lobo, P Saz, G Marcos...
https://pubmed.ncbi.nlm.nih.gov/10422057Actively Recruiting
Led by Universidad de Zaragoza · Updated on 2024-12-12
90
Participants Needed
1
Research Sites
73 weeks
Total Duration
Researchers are evaluating the effectiveness of a personalised and adapted computerised cognitive stimulation program compared to stimulating leisure activities in adults aged 50 years and older who have mild cognitive impairment (MCI) or subjective cognitive impairment. The study focuses on improving global cognition, memory, verbal fluency, daily living activities, and symptoms of depression and anxiety in community-dwelling older adults. This trial is a randomised controlled design involving primary care patients. Participants in the first intervention group will use a computerised cognitive stimulation platform for 30 minutes per day, five days a week, over eight weeks (totaling 40 sessions). This program targets cognitive areas such as memory, orientation, language, calculation, attention, and executive functions. The second group will engage in between two and five cognitively stimulating leisure activities drawn from a questionnaire covering mental, physical, and social activities, performed individually or in groups over the same eight-week period. A control group will receive no intervention during the study but will be offered participation in one of the two interventions afterward. Throughout the study, participants undergo assessments before and after the intervention, with follow-ups at 6 and 12 months. Evaluations include cognitive testing with the Lobo Cognitive Mini-Test (MEC-35) and the Test of Memory Alteration (T@M), alongside questionnaires on lifestyle and clinical characteristics. The study includes socio-demographic data collection and monitors cognitive changes and functional abilities. Total participation spans more than a year with multiple evaluation points to track outcomes and changes over time.
CONDITIONS
Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants in Intervention group 1 carry out personalised and adapted computerised cognitive stimulation for 30 minutes per day, 5 days per week, over 8 weeks. Participants in Intervention group 2 perform between 2 and 5 cognitively stimulating leisure activities for 8 weeks, tracking frequency and group participation. Control group participants do not receive any intervention during this period.
40 sessions for Intervention group 1; frequency varies for Intervention group 2
Duration - 12 months
Participants undergo assessments at 1 week post-intervention, and then at 3, 6, and 12 months to monitor cognitive function and memory.
4 visits (1 week post-intervention, 3 months, 6 months, and 12 months)
Total: 1 location
1
Centro de Salud Arrabal
Zaragoza, Zaragoza, Spain, 50015
Actively Recruiting
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
A Lobo, P Saz, G Marcos...
https://pubmed.ncbi.nlm.nih.gov/10422057M D Calero, E Navarro, P Robles...
https://pubmed.ncbi.nlm.nih.gov/11143500L Rami, B Bosch, C Valls-Pedret...
https://pubmed.ncbi.nlm.nih.gov/19621317Cristóbal Carnero-Pardo, Beatriz Espejo-Martínez, Samuel López-Alcalde...
https://pubmed.ncbi.nlm.nih.gov/22073256L F Pascual Millán, J V Martínez Quiñones, P Modrego Pardo...
https://pubmed.ncbi.nlm.nih.gov/2361045Carlos Muñoz-Neira, Oscar L López, Rodrigo Riveros...
https://pubmed.ncbi.nlm.nih.gov/22797087Caroline B Terwee, Sandra D M Bot, Michael R de Boer...
https://pubmed.ncbi.nlm.nih.gov/17161752R I Pfeffer, T T Kurosaki, C H Harrah...
https://pubmed.ncbi.nlm.nih.gov/7069156Linda G Marc, Patrick J Raue, Martha L Bruce
https://pubmed.ncbi.nlm.nih.gov/18978252D Goldberg, K Bridges, P Duncan-Jones...
https://pubmed.ncbi.nlm.nih.gov/3140969